Amwell (AMWL) Misses Q2 EPS by 11c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amwell Announces Results for Second Quarter 2023
August 2, 2023 4:05 PM EDTBOSTON--(BUSINESS WIRE)-- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced financial results for the second quarter ended June 30, 2023.
Amwell Second Quarter 2023 Highlights:
Recorded Total Revenue of $62.4 million Achieved subscription revenue of $28.0 million Recorded AMG Visit revenue of $28.1 million Reported gross margin of 39% Net loss was ($93.5) million, compared to ($398.5) million in first quarter of 2023. Net loss reflects non-cash goodwill impairment charges of $27.3 million recorded in the second quarter of 2023 and $330.3 million recorded in the first quarter of... More